Global study warns of 40 million deaths from drug-resistant infections by 2050

A new global study warns that drug-resistant infections could lead to nearly 40 million deaths by 2050. The analysis highlights a significant rise in fatalities among people over 70, with overall deaths expected to increase by 70 percent. The study, published in The Lancet, emphasizes the urgent need for action as antimicrobial resistance (AMR) worsens. It coincides with an upcoming UN meeting where countries will discuss commitments to reduce AMR-related deaths by 10 percent by 2030. Concerns also arise over the lack of new antibiotics due to limited financial incentives for pharmaceutical companies. Experts stress the importance of a unified approach to health, linking human, animal, and environmental health to combat AMR effectively.